Neville Rodie & Shaw’s Boston Scientific BSX Stock Holding History

Neville Rodie & Shaw’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$767K	Sell	17,970 -46,800	-72%	-$2.54M	0.05%	145
2026 Q1	$4.06M	Buy	64,770 +18,480	+40%	+$1.48M	0.3%	69
2025 Q4	$4.41M	Sell	46,290 -95	-0.2%	-$9.31K	0.31%	68
2025 Q3	$4.53M	Buy	46,385 +925	+2%	+$95.8K	0.33%	65
2025 Q2	$4.88M	Buy	45,460 +22,255	+96%	+$2.25M	0.36%	63
2025 Q1	$2.34M	Buy	+23,205	New	+$2.34M	0.18%	84

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Neville Rodie & Shaw's BSX Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Boston Scientific (BSX) stake by 72% in Q2 2026, selling an estimated $2.54M and leaving 17,970 shares worth $767K. The position accounts for 0.05% of the portfolio, ranked #145.

Neville Rodie & Shaw first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.88M in Q2 2025. 308 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Neville Rodie & Shaw held 17,970 shares of Boston Scientific worth $767K as of Q2 2026.
Neville Rodie & Shaw sold 46,800 Boston Scientific shares in Q2 2026, an estimated $2.54M.
Boston Scientific made up 0.05% of Neville Rodie & Shaw's portfolio in Q2 2026, its #145 holding.
Neville Rodie & Shaw first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
Neville Rodie & Shaw's Boston Scientific position peaked at $4.88M in Q2 2025.
308 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.